|State Responsbility Area Fire Prevention Fees|
Legislation introduced to repeal current SRA Fire Prevention Fee
Three separate but nearly identical pieces of legislation have been introduced to repeal the current $150 per structure fire prevention fee levied in state responsbility areas(SRAs). An additional bill, SB 125 (Gaines), seeks to provide SRA fee exemptions for structure-owners in fire protection district boundaries. In the meantime, the State Board of Forestry and Fire Protection continues to hold hearings to address concerns related to incorrect billing, protest procedures, and credits for homeowner association and fire protection district fees.
Assembly Bill 23 (Donnelly) - Repeal SRA fees
Assembly Bill 124 (Morrell) - Repeal SRA fees
Senate Bill 17 (Gaines) - Repeal SRA fees
Senate Bill 125 (Gaines) - SRA fee exemption for structures served by fire protection districts
In addition, the Governor's proposed 2013-14 Budget includes $11 million in antipcated SRA fee revenue dedicated to fire prevention services and 65 new CALFIRE positions.
The BFFP released a SRA Viewer on their website that allows you to search specific addresses or general areas to find out if they are in a SRA. If you would like to see if your constituents are located within an SRA, please visit here. This tool may be helpful in notifying your residents of this matter.
Read CSDA SB 1040 Support Letter here
Read Text and Committee Analysis of SB 1040
Read Text and Committee Analysis of AB 2474
Read Text and Committee Analysis of AB 1506
Read 2012 SRA Fee Budget Trailer Bill here
Read Updated DRAFT Regulation here
Read Coalition Oppose Letter of ABx1 24 & SBx1 7 here
Read 9.6.11 CSDA Overview of ABx1 24 & SBx1 7 here
Read 8.29.11 CSDA Overview of Adopted Emergency Regulations here
Read Adopted Emergency Regulation here
Read Text and Committee Analysis of ABx1 29
Tap into CSDA's active Legislative efforts in Sacramento by Logging in:
By increasing the intracellular concentrations of cyclic guanosine monophosphate (cGMP), phosphodiesterase-5 (PDE5) inhibitors such as sildenafil (Viagra), vardenafil (Levitra), and tadalafil (Cialis) have been used therapeutically to treat erectile dysfunction (12), pulmonary hypertension (13), and cardiac hypertrophy (14). More recently, they were shown to induce apoptosis in different human tumors such as colon carcinoma and chronic lymphocyte leukemia (15, 16). In our mouse models, we show that pharmacologic PDE5 blockade down-regulates MDSC suppressive pathways and restores antitumor immunity. Moreover, our in vitro experiments using PBMCs from multiple myeloma (MM) and head and neck cancer patients suggest that the same mechanisms found in mice are also present in humans and demonstrate a possible role for PDE5 inhibitors as an immune adjuvant in the clinical setting. The penis contains two chambers called the corpora cavernosa, which run the length of the organ (see figure 1). A spongy tissue fills the chambers. The corpora cavernosa are surrounded by a membrane, called the tunica albuginea. The spongy tissue contains smooth muscles, fibrous tissues, spaces, veins, and arteries. The urethra, which is the channel for urine and ejaculate, runs along the underside of the corpora cavernosa and is surrounded by the corpus spongiosum. where to buy viagra canadian viagra for sale ANTHONY J. VIERA, LT, MC, USNR, looking for cheap viagra online? 150mg viagra online without prescription buy Viagra 200mg here canadian pharmacy viagra Are you afraid or worried about something? If the veins in the penis cannot prevent blood from leaving the penis during an erection, an erection cannot be maintained. This condition is known as a venous leak. Venous leakage may occur with vascular disease, but it also can occur as a result of poor muscle relaxation of the penis. Difficulty with smooth muscle relaxation of the penis can occur with diabetes or with Peyronie's disease, a condition that results in the buildup of scar tissue of the sheath (tunica albuginea) surrounding the erection tissue (corpora cavernosa). Venous leak also can occur when neurological diseases or high levels of anxiety are present because these conditions can prevent adequate smooth muscle relaxation.